Nov 30, 2022 / 02:30PM GMT
Adam Carl Maeder - Piper Sandler & Co., Research Division - VP & Senior Research Analyst
Good morning. Welcome to the 2022 Piper Sandler Healthcare Conference. My name is Adam Maeder, and I'm one of the med tech analysts here at Piper. Very pleased to introduce the management team from ShockWave Medical. With us, we have Doug Godshall, President and CEO; and Dan Puckett, CFO. Gentlemen, thanks so much for joining us this year.
Douglas E. Godshall - ShockWave Medical, Inc. - President, CEO & Director
Thank you.
Daniel Puckett - ShockWave Medical, Inc. - CFO, Principal Financial Officer & Secretary
Thank you.
Questions and Answers:
Adam Carl Maeder - Piper Sandler & Co., Research Division - VP & Senior Research AnalystSo maybe we can start with the Q3 results. A very nice Q3, a beat-and-raise quarter. The new guidance, by my math, implies Q4 revenue of about $140 million at the midpoint, 6% sequential quarter-over-quarter improvement. You grew